跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
利时敏 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lixisenatide Injection
Approved
化学药品
Lixisenatide Injection
SANOFI WINTHROP INDUSTRIE
🇨🇳 National Medical Products Administration
Approval Date
Mar 15, 2022
Approval ID
8F2ZxtFsQzS
Company
SANOFI WINTHROP INDUSTRIE
Type
化学药品
Approval Details
Approval Id
8F2ZxtFsQzS
Approval Number
国药准字HJ20170371
Generic Name
利司那肽注射液
Generic Name En
Lixisenatide Injection
Trade Name
利时敏
Drug Type
化学药品
Dosage Form
注射剂
Strength
20μg剂量注射笔(深紫红色):0.10mg/ml,3ml/支,单次注射药量20μg(0.2ml)
Reg Date
2022-03-15
Expired Date
2027-03-14
Company Name
SANOFI WINTHROP INDUSTRIE
Company Address
82 avenue Raspail 94250 Gentilly, France
Production Company Name
Sanofi-Aventis Deutschland Gmbh
Production Company Address
Brueningstrasse 50, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
Company Detail Path
/organization/sanofi-winthrop-industrie
Production Company Detail Path
/organization/sanofi-aventis-deutschland-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 15, 2022
Approval ID
8F2ZxtFsQzS
Type
化学药品
Back to NMPA Approvals